MedPath

Trial of Open Versus Laparoscopic Radical Cystectomy at a Laparoscopic Naive Center

Not Applicable
Completed
Conditions
Laparoscopy
Bladder Cancer
Interventions
Procedure: Open radical cystectomy
Procedure: Laparoscopic-assisted radical cystectomy
Registration Number
NCT04838873
Lead Sponsor
Cairo University
Brief Summary

This study is a prospective randomised controlled study of urinary bladder cancer patients presented to urology unit at National Cancer Institute; Cairo University.

Detailed Description

The study will randomise 60 patients to one of two arms; laparoscopic-assisted radical cystectomy and open radical cystectomy. The focus of the study will be a comparison of both approaches on the patients' peri-operative outcome.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Patients with transitional cell carcinoma, squamous cell carcinoma and urinary bladder adenocarcinoma.
  • Patients fit for surgery (ECOG Performance Status 0,1).
Exclusion Criteria
  • Patients with medical comorbidities that preclude surgical management or minimally invasive techniques.
  • Patients with advanced hydronephrosis or renal failure.
  • Patients refusing surgery.
  • Patients with urinary bladder cancer invading bladder neck or prostatic urethra.
  • Patients with metastatic urinary bladder cancer.
  • Patients who received prior pelvic radiotherapy.
  • Patients refusing randomization and/or participation in the trial.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Open Radical CystectomyOpen radical cystectomyStandard open radical cystectomy.
Laparoscopic-assisted radical cystectomy.Laparoscopic-assisted radical cystectomyLaparoscopic-assisted radical cystectomy.
Primary Outcome Measures
NameTimeMethod
Operative timeDuring surgery

OR time as measured in minutes, divided into time required to perform the cystectomy, lymph node dissection, and urinary diversion.

Visceral injuryDuring surgery

Any organ injury encountered during the operation.

Urine leakUp to 4 weeks

Leakage of urine from urinary enteric anastomosis

Wound dehiscence, infection.Up to 4 weeks

Wound gaping, evisceration or infection.

Venous thromboembolismUp to 2 months

DVT or pulmonary embolism

Blood lossDuring surgery

EBL as measured in millilitres, including the effluent from the suction canister as well as estimates of the gauze swabs.

Time to oral intakeImmediate post-operative period

Measured in days

Conversion rateDuring surgery

Rate of conversion from laparoscopy to open surgery

Re-admission rate.Intra-operative to sixth months.

Re-hospitalization requirement.

Opioid requirements.During surgery through first post-operative week.

Requirement, dose and duration of narcotic analgesia.

SepsisUp to 4 weeks

Infection triggering a systematic immune response

Length of hospital stayImmediate post-operative period.

LOS as measured in days

Enteric fistulaUp to 4 weeks

Leakage of intestinal contents due to failure of entero-enteric anastomosis

Secondary Outcome Measures
NameTimeMethod
Lymph node retrievalWithin 10 days post surgery.

Number of lymph nodes retrieved by open versus laparoscopic approaches.

pN stageWithin 10 days post surgery.

Lymph node metastasis (positive or negative), and number of positive nodes if present.

pT stageWithin 10 days post surgery.

Pathologic tumor stage (Stage 1, stage 2, stage 3 or stage 4)

Surgical marginsWithin 10 days post surgery

Positive margins or negative margins. Location of positive margins (Urethral, ureteric)

Histological gradeWithin 10 days post surgery

Low grade, intermediate grade or high grade

Trial Locations

Locations (1)

National Cancer Institute

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath